Browsing by Yonsei Author : Kim, Hye Ryun

Name:
Kim, Hye Ryun [김혜련] http://orcid.org/0000-0002-1842-9070
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Y-HRN :
(Yonsei Health Research Network)
Scopus ID :
(8583782700)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleYonsei Author(s)Type
2020Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer 고윤우, 김다희, 김혜련, 박성용, 박영민Article
2019YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer김혜련, 조병철, 표경호, 홍민희Article
2019Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer김혜련, 박성용, 심효섭, 안병철, 윤홍인, 이진구, 이창영, 조병철, 표경호, 홍민희Article
2019High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma 김대준, 김혜련, 박성용, 신성관, 신수진, 조병철, 홍민희Article
2019Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function 김가민, 김혜련, 라선영, 박성용, 심효섭, 윤홍인, 이진구, 정경영, 조남훈, 조병철Article
2019Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma 김상우, 김혜련, 조병철Article
2019A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13 김혜련Article
2019TRIUMPH Trial: One Small Step Could Become One Giant Leap for Precision Oncology in Head and Neck Cancer 김혜련Article
2019The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer김혜련, 윤홍인, 정인경, 조병철Article
2019A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs김혜련, 조병철, 홍민희Article
2019Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors강은석, 김규리, 김혜련, 이병완, 이용호, 조병철, 차봉수, 홍민희Article
2019Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma김혜련, 박성용, 심효섭, 이창영, 조병철, 홍민희Article
2019Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer 김지형, 김혜련, 안병철, 조병철, 허수진, 홍민희Article
2019Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate김대준, 김혜련, 박성용, 백효채, 서지원, 송승환, 이진구, 이창영, 정경영, 조병철, 홍민희Article
2019Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing김상우, 김혜련, 조병철, 홍민희Article
2019Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma 김혜련, 안병철, 윤미란, 조병철, 표경호, 홍민희Article
2019Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer김시내, 김혜련, 박주영, 변화경, 윤홍인, 이창걸, 조병철, 조연아, 조재호, 홍민희Article
2019Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer 김민환, 김혜련, 박채원, 심효섭, 윤미란, 조병철, 표경호, 홍민희Article
2019Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy김혜련, 박성용, 심효섭, 이창영, 정인경, 조병철, 차윤진, 최은아, 홍민희Article
2019Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice 김혜련, 박성용, 심효섭, 안병철, 윤홍인, 이창영, 조병철, 표경호, 홍민희Article
2018The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control김건민, 김혜련, 라선영, 손주혁Article
2018Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck고윤우, 김진아, 김혜련, 윤선옥, 조병철, 최은창, 홍민희Article
2018Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer김혜련Article
2018ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma강한나, 김혜련, 윤미란, 조병철, 홍민희Article
2018Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy. 고윤우, 금기창, 김세헌, 김혜련, 이정심, 이창걸, 조연아, 최은창Article
2018Radon Exposure-induced Genetic Variations in Lung Cancers among Never Smokers 김혜련Article
2018Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer 강은석, 김혜련, 이병완, 이용호, 이지연, 차봉수, 홍남기Article
2018Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation김대준, 김진아, 김혜련, 박성용, 백순명, 심효섭, 윤미란, 이진구, 이한나, 조병철, 표경호, 홍민희Article
2018A Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal Cancer금기창, 김다희, 김세헌, 김혜련, 조남훈, 조병철Article
2018Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice김혜련, 안병철, 조병철, 홍민희Article
2018Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.김혜련, 심효섭, 조병철, 표경호, 홍민희Article
2017Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization 김혜련, 심효섭, 이진구, 이창영, 정인경, 조병철, 차윤진, 홍민희Article
2017Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma금기창, 김세헌, 김혜련, 박영민, 조남훈, 조병철Article
2017Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs김상우, 김성무, 김혜련, 양인석, 이충근, 조병철Article
2017Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer 김혜련Article
2017Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma김은영, 김진아, 김혜련, 백순명, 심효섭, 이진구, 조병철, 홍민희Article
2017Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study 김혜련, 서창옥, 이창걸, 장종희, 조병철Article
2017Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis 김지형, 김혜련, 박형순, 심효섭, 이진구, 이창영, 조병철, 차윤진, 허수진, 홍민희Article
2017Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer강한나, 김상균, 김성무, 김혜련, 김환, 윤미란, 임선민, 조병철, 표경호Article
2017Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma김은경, 김혜련, 윤선옥, 조병철, 허수진Article
2017Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer김혜련, 박용구, 장원석, 장진우, 정현호, 조병철Article
2017Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study김혜련, 조병철Article
2017A randomized; phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) (vol 8; pg 15943; 2017) 김주항, 김혜련, 정인경, 조병철Article
2017Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer김혜련, 심효섭, 조병철, 차윤진Article
2017Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)김혜련, 조재용Article
2017Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer김혜련, 조병철Article
2017Prevalence and prognostic implications of psychological distress in patients with gastric cancer 김건민, 김경란, 김혜련, 노성훈, 라선영, 송수경, 정현철Article
2017Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.김주항, 김혜련, 심효섭, 임선민, 조병철Article
2016PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients 고윤우, 김은경, 김혜련, 윤선옥, 정인경, 조병철, 최은창, 표경호, 허수진, 홍민희Article
2016Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study김혜련, 조병철Article

Browse